(MCRB) Seres Therapeutics - Performance -53.6% in 12m
Compare MCRB with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-85.34%
#139 in Group
Rel. Strength
8.76%
#7260 in Universe
Total Return 12m
-53.60%
#121 in Group
Total Return 5y
-93.29%
#104 in Group
P/E -
(?) Percentile in Group
P/E Forward 1.08
6th Percentile in Group
PEG -0.11
50th Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: MCRB (-53.6%) vs XBI (-12.3%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: MCRB vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for MCRB
| Total Return (including Dividends) | MCRB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -33.14% | 11.81% | 13.81% |
| 3 Months | -55.73% | -13.61% | -6.30% |
| 12 Months | -53.60% | -12.29% | 10.65% |
| 5 Years | -93.29% | -24.89% | 107.77% |
| Trend Score (consistency of price movement) | MCRB | XBI | S&P 500 |
| 1 Month | -40.8% | 72.9% | 83% |
| 3 Months | -92.1% | -83% | -75.3% |
| 12 Months | -59.0% | -51.6% | 50.1% |
| 5 Years | -85.9% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #195 | -40.2% | -41.3% |
| 3 Month | #173 | -48.8% | -52.8% |
| 12 Month | #121 | -47.1% | -58.1% |
| 5 Years | #108 | -91.1% | -96.8% |
FAQs
Does MCRB Seres Therapeutics outperforms the market?
No,
over the last 12 months MCRB made -53.60%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months MCRB made -55.73%, while XBI made -13.61%.
Over the last 3 months MCRB made -55.73%, while XBI made -13.61%.
Performance Comparison MCRB vs Indeces and Sectors
MCRB vs. Indices MCRB is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -28.0% | -47.0% | -46.4% | -64.3% |
| US NASDAQ 100 | QQQ | -28.2% | -50.5% | -46.7% | -65.2% |
| US Dow Jones Industrial 30 | DIA | -28.4% | -43.1% | -46.2% | -61.3% |
| German DAX 40 | DAX | -28.0% | -48.1% | -72.7% | -79.3% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -30.2% | -45.0% | -47.2% | -61.0% |
| Hongkong Hang Seng | HSI | -31.1% | -53.1% | -54.8% | -67.3% |
| India NIFTY 50 | INDA | -23.1% | -38.0% | -46.9% | -53.4% |
| Brasil Bovespa | EWZ | -29.0% | -50.4% | -55.1% | -45.3% |
MCRB vs. Sectors MCRB is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -28.6% | -46.6% | -53.5% | -75.2% |
| Consumer Discretionary | XLY | -28.4% | -47.4% | -45.5% | -67.9% |
| Consumer Staples | XLP | -27.1% | -39.7% | -53.4% | -62.7% |
| Energy | XLE | -27.8% | -39.9% | -39.9% | -44.1% |
| Financial | XLF | -29.1% | -46.7% | -53.5% | -76.0% |
| Health Care | XLV | -25.0% | -34.0% | -41.5% | -49.5% |
| Industrial | XLI | -29.7% | -50.0% | -47.9% | -64.6% |
| Materials | XLB | -27.8% | -46.7% | -41.6% | -48.4% |
| Real Estate | XLRE | -26.7% | -44.7% | -47.2% | -69.1% |
| Technology | XLK | -29.1% | -54.4% | -43.6% | -60.7% |
| Utilities | XLU | -28.0% | -42.7% | -54.1% | -71.1% |
| Aerospace & Defense | XAR | -30.0% | -54.3% | -57.9% | -80.9% |
| Biotech | XBI | -21.4% | -45.0% | -26.3% | -41.3% |
| Homebuilder | XHB | -28.4% | -44.6% | -33.3% | -46.1% |
| Retail | XRT | -29.9% | -47.8% | -42.2% | -52.1% |